Navigation Links
Cure For Persistent Oral Fungal Problem May Be Possible

Buffalo University dental researchers have identified some proteins that have anti-fungal properties and have the //potential to replace current drugs that are used to treat fungal infections of the mouth.

These peptides have strong anti-fungal properties, even against fungal infections that become resistant to medication. Also the properties of these peptides can be increased if they can be protected from the enzymes that may destroy them.

This may be achieved by synthesizing a protease inhibitor cocktail that may inhibit the enzymes that kill the peptides. This cocktail thus may be able to increase the ability of the peptides to treat potential oral infections up to double their original power.

One peptide called MUC7 12-mer, which occurs naturally in the human salivary mucin molecule is quite effective for treating oral fungal infections. Even active in very low concentrations, when used with inhibitors, the peptide killed the fungal agents that cause very common infections like candidiasis and cryptococcosis. These can be an especially effective treatment for patients having immunity suppressing drugs, like those suffering from HIV-AIDS, Organ transplant patients and chemotherapy patients.

http://www.buffalo.edu/news/fast-execute.cgi/article-
page.html?article=66080009
'"/>




Page: 1

Related medicine news :

1. Persistent Childhood Wheeze Probably Inherited
2. Persistent Fatigue Could Be An Early Indicator Of Postpartum Depression
3. Women More Persistent with Monthly Osteoporosis Treatment
4. Insurance Data Show High Costs of Persistent Asthma
5. Fungal Infections Effectively Controlled By Light Therapy
6. Fungal spores in the pillows can trigger an asthma attack
7. Immunosuppressive Action Of Fungal Metabolite - Gliotoxin
8. Fungal toxins infected corn the reason for congenital defects
9. Contact Lenses Implicated in Fungal Infections
10. Spread Of Fungal Infections At Gym Could Be Avoided By Using Towel
11. Lens Wearers Alerted Over Dangerous Fungal Infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... Mateo, CA (PRWEB) , ... April 28, 2017 , ... ... Area cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce ... allow interested persons to bookmark and read organized content on topics such as home ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to create ... by the continuing support of the Jane and Leonard Korman Family Foundation. The ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a ... Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. ...
(Date:4/27/2017)... Malibu, CA (PRWEB) , ... April 27, 2017 , ... ... United States with an oil many times purer and more potent than the market ... mountain air of Gstaad, Switzerland, as well as a patented chromatography process for extraction, ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... today released the podcast, “Make Plans for MACRA,” highlighting the impact ... the physician's office and how physicians and other clinicians are reimbursed for the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: